Fig. 1From: BRAFV600E mutational status assessment in cutaneous melanocytic neoplasms in a group of the Egyptian populationFour cases of malignant melanoma stained for BRAFV600E. protein (immunoperoxidase × 200) demonstrating: A: Negative cytoplasmic staining in tumour cells (no bleaching) B: Ambiguous staining in tumour cells in the form of nuclear and cytoplasmic staining (prior bleaching) C: Heterogenous positive cytoplasmic staining pattern (no bleaching). D: Homogenous positive cytoplasmic staining pattern. (prior bleaching)Back to article page